Eric Karas
Corporate Officer/Principal bei ARS PHARMACEUTICALS, INC.
Vermögen: - $ am 30.04.2024
Profil
Eric Karas is currently the Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. and ARS Pharmaceuticals, Inc. He previously worked as the Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. Mr. Karas completed his undergraduate degree at Rutgers State University of New Jersey and holds an MBA from Eli Broad College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Eric Karas
| Unternehmen | Position | Beginn |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 08.11.2022 |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.04.2022 |
Ehemalige bekannte Positionen von Eric Karas
| Unternehmen | Position | Ende |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01.03.2022 |
Ausbildung von Eric Karas
| Eli Broad College of Business | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARS PHARMACEUTICALS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
